KGSPF yields 0.77% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 6
Combined, KGSPF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of KGSPF + JNJ for your $10,000?
Kingspan Group plc, together with its subsidiaries, provides insulation and building envelope solutions in the Republic of Ireland, the United Kingdom, rest of Europe, the Americas, and internationally. It operates through five segments: Insulated Panels, Insulation, Light & Air, Water & Energy, and Data & Flooring. The Insulated Panels segment manufactures insulated panels, structural framing, and metal facades components. The Insulation segment provides rigid insulation boards, technical insulation, and engineered timber systems. The Light & Air segment manufactures daylighting, smoke management, and ventilation systems. The Water & Energy segment provides energy and water solutions, and related services. The Data & Flooring segment offers data centre storage solutions, as well as raised access floors. It also engages in the trustee and finance businesses. The company was founded in 1965 and is headquartered in Kingscourt, Ireland.
Full KGSPF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.